Research output per year
Research output per year
Room 03.028 - Whitla Medical Building
United Kingdom
Accepting PhD Students
PhD projects
I am always open to PhD applications in the field of nanopharmaceutical, targeted delivery, smart and novel nanomaterials, exosomes, immunotherapy, tumour microenvironment, and nanotoxicology.
Research activity per year
Dr Al-Jamal is an overseas (Jordan) and a UK-registered pharmacist. She completed her PhD in Nanotechnology and Drug Delivery from London School of Pharmacy (now known as UCL School of Pharmacy), following receiving the prestigious Overseas Research Scholarship (ORS) Award from the University of London. Her PhD research project focused on developing novel liposome-based systems for combinatory therapeutic and diagnostic purposes. In 2008, Dr Al-Jamal joined UCL School of Pharmacy as a Research Fellow focusing on live animal imaging and evaluating organ biodistribution of a variety of novel gene and drug delivery vectors. In 2012, she was appointed at The Institute of Pharmaceutical Science, King’s College London as a Senior Research Associate, focusing on evaluating the behaviour and the efficacy of personalised nanomedicines to treat cancer. Dr Al-Jamal joined the University of East Anglia, Norwich, as a Lecturer in Nanomedicine and Drug Delivery (2013-2014), before being awarded a five-year Career Development Fellowship from Prostate Cancer UK, to develop novel nanomedicines targeting metastatic prostate cancer. In August 2017, Dr Al-Jamal joined Queen’s University Belfast School of Pharmacy as a Reader in Nanomedicine and Drug Delivery.
Dr Al-Jamal is a Visiting Professor at Guizhou Medical School, Guiyang, China. She was the GSK Emerging Scientist Award winner for 2015 for her work in the field of Cancer Nanomedicine. She also received the prestigious international Gro Brundtland Award, Taiwan, that recognizes distinguished female scientists in the field of sustainable development.
Dr Al-Jamal's multidisciplinary team works on developing novel nanomedicines for combinatory therapy and theranostic applications. Currently, her research focuses on developing smart vectors for delivering a broad range of therapeutic agents, and fabricating multifunctional nanoparticles to target cancer and other diseases. Her long-term research career is to facilitate the translation of nanoparticle-based therapeutics from the lab to the clinic.
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Research output: Contribution to journal › Article › peer-review
Research output: Contribution to journal › Article › peer-review
Research output: Contribution to journal › Article › peer-review
Research output: Contribution to journal › Article › peer-review
Research output: Contribution to journal › Article › peer-review
Al-Jamal, Wafa (Recipient), 16 Mar 2017
Prize: National/international honour
Al-Jamal, Wafa (Recipient), 07 Sep 2015
Prize: Prize (including medals and awards)
Al-Jamal, Wafa (Recipient), 31 Mar 2014
Prize: Fellowship awarded competitively
Wafa Al-Jamal (Host)
Activity: Hosting a visitor types › Hosting an academic visitor
Wafa Al-Jamal (Invited speaker)
Activity: Talk or presentation types › Invited talk
Wafa Al-Jamal (Keynote speaker)
Activity: Talk or presentation types › Invited or keynote talk at national or international conference
Wafa Al-Jamal (Keynote speaker)
Activity: Talk or presentation types › Invited or keynote talk at national or international conference
Wafa Al-Jamal (Invited speaker)
Activity: Talk or presentation types › Invited talk